Literature DB >> 28521172

Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.

Faryal Chaudhry1, Shahnaz Choudhry2, Rahila Huma3, Muhammad Ashraf4, Mariya Al-Rashida5, Rubina Munir3, Ramsha Sohail3, Bakhat Jahan4, Munawar Ali Munawar6, Misbahul Ain Khan7.   

Abstract

In search of better α-glucosidase inhibitors, a series of novel hetarylcoumarins (3a-3j) were designed and synthesized through a facile multicomponent route where p-toluenesulfonic acid (PTSA) was explored as an efficient catalyst. These new scaffolds were further evaluated for their α-glucosidase inhibition potentials. All the derivatives exhibited good to excellent results which were comparable or even better than of standard drug acarbose. Of these compounds, a dihalogenated compound 3f was found to be the most effective one with IC50: 2.53±0.002µM. Molecular docking has predicted the plausible binding interactions of compounds 3f, 3g and 3j with α-glucosidase.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidiabetic agents; Coumarin; Imidazole; Molecular docking; α-Glucosidase inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28521172     DOI: 10.1016/j.bioorg.2017.05.009

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Fariba Peytam; Mehdi Adib; Reihaneh Shourgeshty; Maryam Mohammadi-Khanaposhtani; Mehdi Jahani; Somaye Imanparast; Mohammad Ali Faramarzi; Mohammad Mahdavi; Ali Akbar Moghadamnia; Hossein Rastegar; Bagher Larijani
Journal:  Mol Divers       Date:  2019-03-02       Impact factor: 2.943

2.  Synthesis, in vitro [Formula: see text]-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives.

Authors:  Muhammad Ali; Khalid Mohammed Khan; Uzma Salar; Mohammed Ashraf; Muhammad Taha; Abdul Wadood; Sujhla Hamid; Muhammad Riaz; Basharat Ali; Shahbaz Shamim; Farman Ali; Shahnaz Perveen
Journal:  Mol Divers       Date:  2018-05-29       Impact factor: 2.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.